Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment spproaches using vitamin E, magnesium, and betaine - Fatty Liver

Alternative Medicine Review, August, 2002 by Lyn Patrick

References

(1.) Angulo P, Lindor KD. Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issue. Gastroenterology 2001;120:1281-1285.

(2.) Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-1362.

(3.) Ratziu V, Giral P, Frederic C, et al. Liver fibrosis in overweight patients. Gastroenterology 2000;118:1117-1123.

(4.) Powell EE, Cooksley WG, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 1990; 11:74-80.

(5.) Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.

(6.) Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002;35:746-752.

(7.) Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the U.S. population. Gastroenterology 2001 ; 120:A-65.

(8.) Silverman JE O'Brien KF, Long S, et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990;85:1349-1355.

(9.) Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997;42:1428-1432.

(10.) Sokol RJ. The chronic disease of childhood obesity: the sleeping giant has awakened. J Pediatr 2000;136:711-713.

(11.) Byron D, Minuk G. Clinical hepatology: profile of an urban, hospital-based practice. Hepatology 1996;24:813-815.

(12.) Propst A, Propst T, Judamaier G, Vogel W. Prognosis in nonalcoholic steatohepatitis. Gastroenterology 1995; 108:1607.

(13.) Matteoni CA, Younossi ZM, Gramlich T, et al. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.

(14.) Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001;121:710-723.

(15.) Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc 2000;75:733-739.

(16.) Moshin R, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000;30:48-53.

(17.) George DK, Goldwurm S, Macdonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-318.

(18.) Dixon JB, Bhatal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.

(19.) Prevalence of overweight and obesity among adults: U.S. 1999. U.S. Department of Health and Human Services. Center for Disease Control and Prevention. National Center for Health Statistics. Division of Data Services. Hyattsville, MD. 20782-2003.

(20.) Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002;35:367-372.